Expression of CD98hc in Pancreatic Cancer and Its Role in Cancer Cell Behavior

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Cluster of differentiation 98 heavy chain (CD98hc) is a transmembrane protein involved in integrin signaling and amino acid transport.
• CD98hc plays a role in cell cycle regulation and stress protection, and its overexpression is linked to poor prognosis in various cancers.
• The specific role of CD98hc in pancreatic cancer has not been fully understood.

Purpose of the Study:

• To investigate the expression of CD98hc in pancreatic ductal adenocarcinoma (PDAC).
• To determine the functional role of CD98hc in pancreatic cancer cell biology.
• To assess the potential of CD98hc as a therapeutic target in PDAC.

Main Methods:

• Immunohistochemical staining for CD98hc was performed on 222 PDAC tissue samples.
• Pancreatic cancer cell lines (PANC-1, BxPC-3) were used for in vitro assays including cell adhesion, trans-migration, and spreading.
• Flow cytometry assessed apoptosis rates, and shRNA-lentiviral constructs were used for CD98hc knockdown and reconstitution.

Main Results:

• CD98hc expression was observed in 13% of acinar cells and 20% of islet cells within PDAC tissues.
• While not associated with tumor stage or grade, CD98hc expression showed a trend towards reduced overall survival in patients.
• In vitro, CD98hc downregulation significantly inhibited proliferation, self-renewal, and anchorage-independent growth of pancreatic cancer cells.

Conclusions:

• CD98hc is expressed in a significant proportion of pancreatic ductal adenocarcinomas.
• CD98hc influences key cancer cell behaviors, including proliferation and growth.
• CD98hc represents a promising molecular target for future pancreatic cancer therapeutic strategies.